Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

NCT00482755 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: sunitinib malate
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: needle biopsy
PROCEDURE: neoadjuvant therapy

Sponsor

NCIC Clinical Trials Group